|
Acne vulgaris is a skin condition that commonly affects adolescents and young adults, including athletes. Acne seldom precludes athletic participation, except in cases as described above. Athletes using anabolic steroids may create recalcitrant cystic acne on their backs and shoulders. Occasionally, acne is indicatory of systemic illness, such as polycystic ovary syndrome. Most commonly, however, acne is a skin problem resulting in poor cosmetic appearance. Although poor cosmesis may seem of minor importance to the physician, this may be rather ravaging to patients. Identifying the rectify subtype and severity of acne will concede the practitioner to tailor a treatment system to each patient’s specific needs. Physicians have a wide assortment of choices available for the treatment of acne, and a heap of are more effective for queer acne subtypes than others. Side effects of acne therapy are in general low, even though oral antibiotics and isotretinoin carry potentially substantial side effects. Appropriate therapy will concede the athlete with acne to proceed taking part in sports, minimize medication side effects, and improve self selfassurance as well as the aspect of the skin. Although the diagnosis of acne vulgaris is reasonably straightforward, other acneiform disorders must be included in the differential diagnosis. Hot tub folliculitis, Malassezia folliculitis, and rosacea are mutual disorders that may be confused with acne vulgaris. Hot tub folliculitis is a self-limited condition caused by colonization of follicles with Pseudomonas aeruginosa. The condition in general gives rise to after the patient sits in a communal hot tub, and it resolves spontaneously within 1 to 2 weeks. Another type of folliculitis is caused when the yeast Malassezia ovale colonizes the follicles. It is characterized by pruritic follicular papules and pustules on the trunk, back, and upper arms. Absence of comedones and response to antifungal creams helps discern this condition from acne vulgaris. Although rosacea is a distinct condition, it is a chronic disorder affecting the face that commonly coexists with acne vulgaris. Early stages of rosacea are characterized by persistent erythema and development of telangiectasia. Later stages of rosacea implicate the development of papules and pustules that may be mistaken for the lesions of acne vulgaris. Initiating Treatment Effective acne therapy begins with patient education. Myths surrounding etiologic components are widely believed by adolescents. A survey of teenagers revealed that a heap of believed that consuming greasy feed (64 percent) or chocolate (50 percent) was responsible for the development of acne. Dispelling these widely held incorrect conceptions and instructing the patient on an suitable tame cleansing regimen are cornerstones of acne therapy. For most patients, washing twice a day is sufficient. Patients ought to also be counseled to keep out of the way of comedogenic substances found in numerous cosmetics, whenever possible. An exception to this counsel is the use of sunblock for athletes competing in outdoor activenesses and for people who are in need of medical care using oral antibiotics that cause photosensitivity. Some sunblock and sunscreen lotions incorporate comedogenic substances; in general, an oil-free water-based sunscreen is best. After educating the patient, the physician may choose to begin therapy with medications, including topical retinoids, topical antimicrobials, oral antimicrobials, and oral isotretinoin. These medications are effective in treating acne vulgaris by one or more of four key mechanisms of action: correcting altered follicular keratinization, decreasing sebum production, reducing bacterial colonization, or devising an anti-inflammatory effect. Topical retinoids, derivatives of vitamin A, treat acne by furthering normal epithelial desquamation. These medications act as keratolytics and reduce comedo formation. Topical retinoids are first-line agents for comedonal acne, and, because comedones are precursors of inflammatory lesions, they are effective adjuncts in the treatment of inflammatory acne. Commonly employed topical retinoids are adapalene, tazarotene, and tretinoin. Use of the topical retinoids for treatment of both comedonal and inflammatory lesions is supported in the literature. A randomized controlled trial comparing the effectiveness of tazarotene 0.1 percent and 0.05 percent gels with a placebo gel noted a 52 percent reduction in total lesions with tazarotene versus a 33 percent reduction with placebo for mild to moderate facial acne. The topical retinoids vary somewhat in efficacy when equated with one another. A meta-analysis of five randomized tryouts involving 900 people who are in need of medical care with mild to moderate acne vulgaris revealed that with monotherapy, total lesion counts dropped by 53 percent with tretinoin 0.025 percent gel and by 57 percent with adapalene 0.1 percent gel. Adapalene demonstrated more rapid efficacy and substantially dandier local tolerability than tretinoin. A randomized controlled trial comparing tazarotene 0.1 percent gel and tretinoin 0.025 percent gel found a 54 percent reduction in the number of inflammatory lesions with tazarotene equated with 44 percent with tretinoin. Another randomized controlled trial revealed that tazarotene 0.1 percent gel scaled down inflammatory lesions by 70 percent and noninflammatory lesions by 71 percent, equated with reductions of 55 percent and 48 percent observed with adapalene 0.1 percent gel. Both treatments were well tolerated, and tazarotene was more cost effective. Common side effects of topical retinoid therapy include photosensitivity, erythema, dryness, and desquamation. Adapalene 0.1 percent gel was equated with isotretinoin 0.05 percent gel and 0.05 percent tretinoin cream for treatment of inflammatory acne in two recent studies. All three preparations significantly scaled down inflammatory lesions, but adapalene was related with significantly less side effects. Tazarotene is related with more local inflammation when equated with adapalene and tretinoin. In summary, the topical retinoids have been shown to be effective monotherapeutic agents for comedonal and mild inflammatory acne. The biggest reductions in total lesion counts were observed with tazarotene 0.1 percent gel. Adapalene 0.1 percent gel induces less averse effects, which may improve patient compliance and overall outcomes. Because topical retinoids induce photosensitivity, active persons who requires medical care will have to stay clear from exuberant sun exposure and liberally use sunblock when taking part in outdoor venues. |



